This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Mindray Medical International Ltd (MR)

NYSE: Health Care

Company Cash Flow
Dec 2013 Dec 2012 Dec 2011 Dec 2010
Cash Flow From Operating Activities
Net Income (Loss) 230.55M 180.21M 166.63M 155.47M
Operating Gains/Losses -91.00K 2.11M -1.57M 5.00K
Extraordinary Gains / Losses 0.00 0.00 0.00 0.00
(Increase) Decrease In Receivables -22.79M -2.83M -51.10M -35.62M
(Increase) Decrease in Inventories -18.98M -11.18M -15.19M -13.77M
(Increase) Decrease In Other Current Assets 0.00 -1.11M 0.00 0.00
(Decrease) Increase In Payables 27.66M 48.88M 5.47M 7.23M
(Decrease) Increase In Other Current Liabilities -6.43M 10.42M 12.72M -4.60M
(Increase) Decrease In Other Working Capital 28.70M 29.49M 26.08M -298.00K
Other Non-Cash Items 15.90M 27.31M 14.84M 8.74M
Net Cash From Continuing Operations 307.92M 325.67M 192.40M 147.70M
Net Cash From Discontinued Operations 0.00 0.00 0.00 0.00
Cash Provided By Investing Activities
Net Cash From Total Operating Activities 307.92M 325.67M 192.40M 147.70M
Sale of Property, Plant & Equipment 741.00K 1.77M 4.53M 338.00K
Cash Used for Investing Activities
Sale of Short-Term Investments 652.90M 144.40M 100.27M 0.00
Purchases of Property, Plant & Equipment -109.08M -65.60M -76.24M -65.92M
Acquisitions -109.38M -34.55M -6.53M 0.00
Purchases of Short-Term Investments -863.04M -257.02M -264.12M -296.00M
Other Cash from Investing Activities 3.32M -21.53M -16.19M 73.26M
Cash Provided by Financing Activities
Net Cash From Investing Activities -424.54M -232.54M -258.28M -187.37M
Issuance of Debt 0.00 52.00M 85.40M 0.00
Cash Used for Financing Activities
Issuance of Capital Stock 16.09M 24.59M 7.12M 11.16M
Repayment of Long-Term Debt -35.00M -2.48M 0.00 -169.07M
Repurchase of Capital Stock -42.37M 0.00 -10.16M 0.00
Payment of Cash Dividends -59.07M -46.40M -34.52M -22.80M
Other Financing Charges, Net 371.72M 506.00K 797.00K 149.66M
Net Cash From Financing Activities 251.37M 28.22M 48.64M -31.04M
Effect of Exchange Rate Changes 2.62M 2.20M 4.05M 3.99M
Net Change in Cash & Cash Equivalents 137.36M 123.55M -13.19M -66.73M
MR News

MR Mindray Medical International Ltd

Analysts Ratings for MR

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 2 2 2 2
Moderate Buy 0 0 0 0
Hold 3 3 3 3
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET MR ANALYST REPORT

Brokerage Partners

MR Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Breakout Stocks

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs